133 related articles for article (PubMed ID: 37802701)
101. Microwave ablation combined with lipiodol-microsphere mixed or conventional transarterial chemoembolization for the treatment of colorectal liver metastases: A retrospective study.
Shi Q; Wang F; Du N; Zhou Y; Zhou X; Ma J; Yang M; Zhang Z; Yu J; Zhang W; Luo J; Liu L; Yan Z
Clin Res Hepatol Gastroenterol; 2022; 46(7):101986. PubMed ID: 35772684
[TBL] [Abstract][Full Text] [Related]
102. Surgical Management of Neuroendocrine Tumor Liver Metastases.
Tran CG; Sherman SK; Chandrasekharan C; Howe JR
Surg Oncol Clin N Am; 2021 Jan; 30(1):39-55. PubMed ID: 33220808
[TBL] [Abstract][Full Text] [Related]
103. Outcomes after Surgical Microwave Ablation for the Treatment of Colorectal Liver Metastasis.
Wells AB; Butano VW; Phillips MC; Mckillop IH; Martinie JB; Baker EH; Iannitti DA
J Am Coll Surg; 2024 Apr; ():. PubMed ID: 38651746
[TBL] [Abstract][Full Text] [Related]
104. Live to fight another day: Combining parenchymal sparing resection and ablative therapy in neuroendocrine tumor liver metastases.
Bello RJ; Clarke CN
Am J Surg; 2024 Mar; 229():15-16. PubMed ID: 37985321
[No Abstract] [Full Text] [Related]
105. Debulking hepatectomy: The glass is half full.
Cho JY
Surg Oncol; 2024 Mar; ():102065. PubMed ID: 38514369
[No Abstract] [Full Text] [Related]
106. CAN MICROWAVE ABLATION BE AN ALTERNATIVE TO RESECTION FOR THE TREATMENT OF NEUROENDOCRINE LIVER METASTASES?
Perrodin SF; Renzulli MM; Maurer MH; Kim-Fuchs C; Candinas D; Beldi G; Lachenmayer A
Endocr Pract; 2020 Apr; 26(4):378-387. PubMed ID: 31859556
[No Abstract] [Full Text] [Related]
107. Operative Microwave Ablation for the Multimodal Treatment of Neuroendocrine Liver Metastases.
Pickens RC; Sulzer JK; Passeri MJ; Murphy K; Vrochides D; Martinie JB; Baker EH; Ocuin LM; McKillop IH; Iannitti DA
J Laparoendosc Adv Surg Tech A; 2021 Aug; 31(8):917-925. PubMed ID: 33296283
[No Abstract] [Full Text] [Related]
108. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
[TBL] [Abstract][Full Text] [Related]
109. Thermal Ablation of Colorectal Lung Metastases: Retrospective Comparison Among Laser-Induced Thermotherapy, Radiofrequency Ablation, and Microwave Ablation.
Vogl TJ; Eckert R; Naguib NN; Beeres M; Gruber-Rouh T; Nour-Eldin NA
AJR Am J Roentgenol; 2016 Dec; 207(6):1340-1349. PubMed ID: 27680945
[TBL] [Abstract][Full Text] [Related]
110. Single center outcomes from parenchymal-sparing resections and microwave ablations for neuroendocrine tumor liver metastases.
Lee FT; Williams J; Nordgren R; Schwarz JL; Setia N; Roggin K; Polite B; Rangrass G; Liao CY; Millis JM; Keutgen XM
Am J Surg; 2024 Mar; 229():17-23. PubMed ID: 37802701
[TBL] [Abstract][Full Text] [Related]
111. Hepatic surgery for metastases from neuroendocrine tumors.
Sarmiento JM; Que FG
Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
[TBL] [Abstract][Full Text] [Related]
112. Defining a New Classification System for the Surgical Management of Neuroendocrine Tumor Liver Metastases.
Mahuron KM; Singh G
J Clin Med; 2023 Mar; 12(7):. PubMed ID: 37048539
[TBL] [Abstract][Full Text] [Related]
113.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
114.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
115.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
116.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
117.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
118.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
119.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
120.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
